My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2024/893 of 22 March 2024 approving thermally treated garlic juice as an existing active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Implementing Regulation (EU) 2024/893 of 22 March 2024 approving thermally treated garlic juice as an existing active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Implementing Regulation (EU) 2024/893 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Thermally treated garlic juice is approved as an active substance for use in biocidal products of product-type 19, subject to the conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Date of approval Expiry date of approval Product type Specific conditions Thermally treated garlic juice Thermally treated garlic juice EC No: — CAS No: — Thermally treated garlic juice is an unknown or variable composition, complex reaction products or of biological materials (UVCB) substance. The purity is 100 % weight per weight (w/w). It is derived from garlic juice that is thermally treated and has food grade quality. In addition, thermally treated garlic juice is characterised by four marker compounds: diallyl sulfide (DAS1), diallyl disulfide (DAS2), diallyl trisulfide (DAS3) and diallyl tetrasulfide (DAS4). 1 July 2025 30 June 2035 19 The authorisation of biocidal products is subject to the following condition:   the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Other acts of the same type
Commission Regulation (EU) 2025/130 of 28 January 2025 amending Regulation (EC) No 865/2006 as regards developments in the framework of the Convention on International Trade in Endangered Species of Wild Fauna and Flora and the possibility to issue retrospective permitsCommission Implementing Regulation (EU) 2025/132 of 28 January 2025 amending Implementing Regulation (EU) No 792/2012 as regards the inclusion of a reference to musical instruments certificates and explanations for the use of formsCommission Implementing Regulation (EU) 2025/133 of 28 January 2025 amending Regulation (EU) No 965/2012 as regards non-commercial operations conducted in visual flight rules conditions with gyroplanesCommission Implementing Regulation (EU) 2025/134 of 28 January 2025 amending Regulation (EU) No 1178/2011 as regards the introduction of a gyroplane pilot licenceCommission Implementing Regulation (EU) 2025/184 of 28 January 2025 amending Implementing Regulations (EU) 2020/761 and (EU) 2020/1988 regarding the creation, modification and management of certain tariff quotas following the Interim Agreement on Trade between the European Union and the Republic of ChileCommission Implementing Regulation (EU) 2025/203 of 28 January 2025 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for Canada, the United Kingdom and the United States in the lists of third countries, territories or zones thereof authorised for the entry into the Union of consignments of poultry and germinal products of poultry, and of fresh meat of poultry and game birdsCommission Delegated Regulation (EU) 2025/855 of 28 January 2025 amending the regulatory technical standards laid down in Delegated Regulation (EU) 2021/931 as regards the specification of the formula for calculating the supervisory delta of call and put options mapped to the commodity risk categoryCommission Implementing Regulation (EU) 2025/127 of 27 January 2025 correcting certain language versions of Implementing Regulation (EU) 2021/808 on the performance of analytical methods for residues of pharmacologically active substances used in food-producing animals and on the interpretation of results as well as on the methods to be used for samplingCouncil Implementing Regulation (EU) 2025/173 of 27 January 2025 implementing Regulation (EU) 2019/796 concerning restrictive measures against cyber-attacks threatening the Union or its Member StatesCouncil Implementing Regulation (EU) 2025/190 of 27 January 2025 implementing Regulation (EU) 2016/44 concerning restrictive measures in view of the situation in LibyaCommission Implementing Regulation (EU) 2025/117 of 24 January 2025 laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medical devices and in vitro diagnostic medical devicesCommission Implementing Regulation (EU) 2025/119 of 24 January 2025 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the low-risk active substance aqueous extract from the germinated seeds of sweet Lupinus albus

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next